The Affordable Medicines Program List Has Been Updated — Original Innovative Medicines Are Now Available to Patients
As part of the implementation of the state policy and Government priorities in healthcare, the List of medicines eligible for reimbursement under the Affordable Medicines program has been expanded.
As part of the implementation of the state policy and Government priorities in healthcare, the List of medicines eligible for reimbursement under the Affordable Medicines program has been expanded.
The List now includes, in particular, original innovative medicines used to treat cardiovascular diseases, prevent strokes and thromboses, treat type 2 diabetes, and treat chronic respiratory diseases.
These include medicines based on rivaroxaban (Ksarelto and its generic equivalent), dabigatran (Pradaksa), apixaban (Elikvis), dapagliflozin (Forksiha), empagliflozin (Dzhardins), as well as medicines based on atorvastatin and combination medicines for treating chronic lung diseases. Their inclusion in the program expands patients’ access to therapy, which was previously financially out of reach for a significant proportion of people.
A key feature of the update is the use of a fixed reimbursement amount mechanism for some of the new medicines (Elikvis, Pradaksa, Forksiha, Dzhardins, Ksarelto). The state pays a specified portion of the medicine’s cost, while the patient’s co-payment is the difference between the medicine’s actual price at the pharmacy and the reimbursement amount. The state-funded portion remains fixed, while the patient’s actual co-payment may be lower if the medicine’s price at the pharmacy is lower. This approach immediately creates the conditions to reduce patients’ treatment costs.
Importantly, adding new medicines to the List does not involve introducing additional procedures for doctors or patients. Prescriptions are issued as part of standard clinical practice, according to the patient’s condition and medical indications. An electronic prescription may be issued by:
There is no need to create or update treatment plans in the electronic healthcare system for these medicines.
The medicines can be obtained through the program at 17 348 pharmacies across the country. You can find a pharmacy on the NSZU “Electronic map of locations dispensing medicines by e-prescription”.
The current List of medicines and medical devices as of 30 April 2026 is available on the NSZU website.
As of now, including the latest update, it contains 778 items:
Of these, 284 are completely free for patients, and 494 require a partial co-payment.
Since 2019, more than 6,18 million patients have used the program. Since the beginning of 2026 alone, 1,95 million patients have received medicines, and more than 3,5 million electronic prescriptions have been filled.
The latest expansion of the Affordable Medicines program is part of the systematic work of the Government, MOZ and NSZU to expand Ukrainians’ access to modern medicines that help prevent and control the progression of diseases, reduce the risk of complications, ensure uninterrupted treatment for patients with chronic conditions, and reduce the financial burden on citizens.